A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α
HM Horton, D Anderson, P Hernandez… - Proceedings of the …, 1999 - National Acad Sciences
A cancer treatment is described in which im injection of plasmid DNA (pDNA) encoding
murine interferon α (mIFN-α) leads to potent antitumor effects on primary and metastatic …
murine interferon α (mIFN-α) leads to potent antitumor effects on primary and metastatic …
Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
A Gambotto, T Tüting, DL McVey, I Kovesdi… - Cancer gene …, 1999 - nature.com
Direct intratumoral (it) injection of adenoviruses (Ads) expressing specific
immunostimulatory cytokines represents an attractive strategy for the clinical implementation …
immunostimulatory cytokines represents an attractive strategy for the clinical implementation …
Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation
G Lazennec, JL Alcorn… - Molecular …, 1999 - academic.oup.com
Dominant negative estrogen receptors are transcriptionally inactive, altered forms of the
estrogen receptor (ER) that can dimerize with the ER and have the potential to inactivate the …
estrogen receptor (ER) that can dimerize with the ER and have the potential to inactivate the …
Complementary adenoviral vectors for oncolysis
R Alemany, S Lai, YC Lou, HY Jan, X Fang… - Cancer gene …, 1999 - nature.com
Replication-competent adenoviruses (Ads) were used for oncolytic virotherapy soon after
they were discovered. Recently mutated and genetically engineered Ads have been shown …
they were discovered. Recently mutated and genetically engineered Ads have been shown …
Antitumor Effects of Interferon-ω: In Vivo Therapy of Human Tumor Xenografts in Nude Mice
HM Horton, P Hernandez, SE Parker, KM Barnhart - Cancer research, 1999 - AACR
The antitumor effect of the type I IFN, IFN-ω, was evaluated in both in vitro and in vivo studies
of human cancer. For these studies, the cDNA for human IFN-ω was cloned into a eukaryotic …
of human cancer. For these studies, the cDNA for human IFN-ω was cloned into a eukaryotic …
Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry
CM Schmidt, SL Settle, JL Keene, WF Westlin… - Clinical & experimental …, 1999 - Springer
Studies of metastasis can be accelerated and provide more mechanistic information using
cell lines which reproducibly and aggressively metastasize, and which are accurately and …
cell lines which reproducibly and aggressively metastasize, and which are accurately and …
In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery
A replication-deficient adenovirus encoding human interferon alpha 2b, driven by the human
cytomegalovirus (CMV) promoter, was constructed and characterized. This construct was …
cytomegalovirus (CMV) promoter, was constructed and characterized. This construct was …
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and …
G D'Agostino, E Arico, L Santodonato… - Journal of interferon & …, 1999 - liebertpub.com
In this study, we investigated the effects of human type I consensus interferon (IFN-
con1)(Amgen) gene transfer into body cavity-based lymphomas (BCBL)-1 cells, which are …
con1)(Amgen) gene transfer into body cavity-based lymphomas (BCBL)-1 cells, which are …
Distinct Effect of Retroviral-Mediated IFN-alpha Gene Transfer on Human Erythroleukemic and CD34+ Cell Growth and Differentiation
S Quan, E Feldman, L Yang, FA Wagener… - … of Hematotherapy & …, 1999 - liebertpub.com
Human interferon-alpha (IFN-alpha) has been used in the management of leukemia, but its
diverse adverse effects may influence the ability of IFN-alpha to treat this disease. We …
diverse adverse effects may influence the ability of IFN-alpha to treat this disease. We …
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
JG Barsoum, XQ Qin - 1999 - Google Patents
UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S, 2R, 3R, 4S, 5R, 6R)-3-carbamimidamido-6-
{[(2R, 3R, 4R, 5S)-3-{[(2S, 3S, 4S, 5R, 6S)-4, 5-dihydroxy-6-(hydroxymethyl)-3 …
{[(2R, 3R, 4R, 5S)-3-{[(2S, 3S, 4S, 5R, 6S)-4, 5-dihydroxy-6-(hydroxymethyl)-3 …